Stock price when the opinion was issued
He does not own this one. They have an effective covered call strategy and has no issues with the fund at all. He prefers ZUH, where it is not impeded with calls being written.
Billy Kawasaki’s Insights - Picks from 5i Research. Healthcare is likely to be a strong performer in the next five years. Subsectors like medical devices, telemedicine and therapeutics should lead. A good ETF for US exposure. Unlock Premium - Try 5i Free
They use a covered call strategy to enhance the yield. Those who want exposure to healthcare space but want higher yield, it is a good option. If yield is not a concern for you, you're better off with ZUH.
(A Top Pick Feb 17/15. Down 9.16%.) This is down because there was not the pickup from the US$, as well as all the questions about mispricing among the big pharmas. Still likes this, because it is not that big on just pharma, but is also in hospital management and different kinds of services. Thinks there is going to be a pretty good market for health services over the next several years. If there is any weakness in it, buy it.